公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2019 | A simple non-invasive test for ruling out cirrhosis in chronic hepatitis B | TAI-CHUNG TSENG ; Shih Y.-F.; CHUN-JEN LIU | The Lancet Gastroenterology and Hepatology | 0 | 0 | |
2019 | Smoking and Hepatitis B Virus–Related Hepatocellular Carcinoma Risk: The Mediating Roles of Viral Load and Alanine Aminotransferase | Wang Y.-H.; YA-HUI CHUANG ; Wu C.-F.; Jan M.-C.; Wu W.-J.; Lin C.-L.; CHUN-JEN LIU ; YA-CHIEN YANG ; PEI-JER CHEN ; Lin S.-M.; MONG-HSUN TSAI ; Huang Y.-W.; MING-WHEI YU | Hepatology | 23 | 24 | |
2019 | Sofosbuvir-based direct acting antiviral therapies for patients with hepatitis C virus genotype 2 infection | CHEN-HUA LIU ; TUNG-HUNG SU ; CHUN-JEN LIU ; CHUN-MING HONG ; HUNG-CHIH YANG ; TAI-CHUNG TSENG ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Journal of Gastroenterology and Hepatology (Australia) | 14 | 15 | |
2022 | Sofosbuvir-based direct-acting antivirals for patients with decompensated hepatitis C virus-related cirrhosis | CHEN-HUA LIU ; CHUN-JEN LIU ; JIA-HORNG KAO | Journal of the Chinese Medical Association : JCMA | 0 | 0 | |
2018 | Sofosbuvir-based Interferon-Free Direct Acting Antiviral Regimens for Heart Transplant Recipients with Chronic Hepatitis C Virus Infection | CHEN-HUA LIU ; YIH-SHARNG CHEN ; SHOEI-SHEN WANG ; CHUN-JEN LIU ; TUNG-HUNG SU ; HUNG-CHIH YANG ; CHUN-MING HONG ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Clinical Infectious Diseases | 26 | 21 | |
2022 | Sofosbuvir/Velpatasvir for Hepatitis C Virus Infection: Real-World Effectiveness and Safety from a Nationwide Registry in Taiwan | Cheng P.-N.; Mo L.-R.; Chen C.-T.; Chen C.-Y.; Huang C.-F.; Kuo H.-T.; Lo C.-C.; Tseng K.-C.; Huang Y.-H.; Tai C.-M.; Peng C.-Y.; Bair M.-J.; Chen C.-H.; Yeh M.-L.; Lin C.-L.; Lin C.-Y.; Lee P.-L.; Chong L.-W.; Hung C.-H.; Chang T.S.; Huang J.-F.; Yang C.-C.; Hu J.-T.; Lin C.-W.; Wang C.-C.; Su W.-W.; Hsieh T.-Y.; Lin C.-L.; Tsai W.-L.; Lee T.-H.; Chen G.-Y.; Wang S.-J.; Chang C.-C.; Yang S.-S.; Wu W.-C.; Huang C.-S.; Chou K.-H.; Kao C.-N.; Tsai P.-C.; CHEN-HUA LIU ; Lee M.-H.; Cheng C.-Y.; Tsai M.-C.; CHUN-JEN LIU ; Dai C.-Y.; Lin H.-C.; JIA-HORNG KAO ; Chuang W.-L.; Yu M.-L.; TACR investigators | Infectious Diseases and Therapy | 9 | 8 | |
2021 | Sofosbuvir/velpatasvir for patients with chronic hepatitis C virus infection and compensated liver disease: real-world data in Taiwan | CHEN-HUA LIU ; Chen P.-Y.; Chen J.-J.; Lo C.-C.; Su W.-W.; Tseng K.-C.; CHUN-JEN LIU ; Huang C.-S.; Huang K.-J.; Yang S.-S.; Peng C.-Y.; Tsai M.-C.; Kao W.-Y.; Chang C.-Y.; Shih Y.-L.; YU-JEN FANG ; Chen C.-Y.; Lee P.-L.; Huang J.-J.; Su P.-Y.; Tseng C.-W.; CHIEN-CHING HUNG ; Chang C.-H.; Huang Y.-J.; Lai H.-C.; Chang C.-C.; Lee F.-J.; Hsieh T. Y.; JIA-HORNG KAO | Hepatology International | 14 | 14 | |
2021 | Sofosbuvir/velpatasvir plus ribavirin for child-pugh b and child-pugh c hepatitis c virus-related cirrhosis | CHEN-HUA LIU ; Chen C.-Y.; Su W.-W.; CHUN-JEN LIU ; Lo C.-C.; Huang K.-J.; Chen J.-J.; Tseng K.-C.; Chang C.-Y.; Peng C.-Y.; Shih Y.-L.; Huang C.-S.; Kao W.-Y.; Yang S.-S.; Tsai M.-C.; Wu J.-H.; Chen P.-Y.; Su P.-Y.; Hwang J.-J.; YU-JEN FANG ; Lee P.-L.; Tseng C.-W.; Lee F.-J.; Lai H.-C.; Hsieh T.-Y.; Chang C.-C.; Chang C.-H.; Huang Y.-J.; JIA-HORNG KAO | Clinical and Molecular Hepatology | 8 | 8 | |
2020 | Sofosbuvir/velpatasvir with or without low-dose ribavirin for patients with chronic hepatitis C virus infection and severe renal impairment | CHEN-HUA LIU ; Chen C.-Y.; Su W.-W.; Tseng K.-C.; Lo C.-C.; CHUN-JEN LIU ; Chen J.-J.; Peng C.-Y.; Shih Y.-L.; Yang S.-S.; Huang C.-S.; Huang K.-J.; Chang C.-Y.; Tsai M.-C.; Kao W.-Y.; YU-JEN FANG ; Chen P.-Y.; Su P.-Y.; Tseng C.-W.; Huang J.-J.; Lee P.-L.; Lai H.-C.; Hsieh T.-Y.; Chang C.-H.; Huang Y.-J.; Lee F.-J.; Chang C.-C.; JIA-HORNG KAO | Gut | 26 | 27 | |
2023 | Sofosbuvir/velpatasvir/voxilaprevir for patients with chronic hepatitis C virus infection previously treated with NS5A direct-acting antivirals: a real-world multicenter cohort in Taiwan | CHEN-HUA LIU ; Peng, Cheng-Yuan; CHUN-JEN LIU ; Chen, Chi-Yi; Lo, Ching-Chu; Tseng, Kuo-Chih; Su, Pei-Yuan; Kao, Wei-Yu; Tsai, Ming-Chang; Tung, Hung-Da; Cheng, Hao-Tsai; Lee, Fu-Jen; Huang, Chia-Sheng; Huang, Ke-Jhang; Shih, Yu-Lueng; Yang, Sheng-Shun; Wu, Jo-Hsuan; Lai, Hsueh-Chou; YU-JEN FANG ; Chen, Po-Yueh; Hwang, Jow-Jyh; Tseng, Chi-Wei; Su, Wei-Wen; Chang, Chun-Chao; Lee, Pei-Lun; Chen, Jyh-Jou; Chang, Chi-Yang; Hsieh, Tsai-Yuan; Chang, Chung-Hsin; Huang, Yi-Jie; JIA-HORNG KAO | Hepatology international | 5 | 4 | |
2020 | Sofosbuvir/velpatasvir/voxilaprevir plus ribavirin for chronic hepatitis C patients with direct acting antiviral failures: Implications for viral elimination in Taiwan | CHEN-HUA LIU ; TUNG-HUNG SU ; CHUN-JEN LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Journal of the Formosan Medical Association | 4 | 4 | |
2015 | Sorafenib and its derivative SC-1 exhibit antifibrotic effects through signal transducer and activator of transcription 3 inhibition | TUNG-HUNG SU ; Shiau C.-W; Jao P; CHEN-HUA LIU ; CHUN-JEN LIU ; Tai W.-T; YUNG-MING JENG ; HUNG-CHIH YANG ; TAI-CHUNG TSENG ; HSIANG-PO HUANG ; Cheng H.-R; PEI-JER CHEN ; Chen K.-F; JIA-HORNG KAO ; DING-SHINN CHEN | Proceedings of the National Academy of Sciences of the United States of America | 66 | 62 | |
2023 | Splenic Arterial Pulsatility Index to Predict Hepatic Fibrosis in Hemodialysis Patients with Chronic Hepatitis C Virus Infection | CHEN-HUA LIU ; YU-JEN FANG ; CHUN-JEN LIU ; TUNG-HUNG SU ; SHANG-CHIN HUANG ; TAI-CHUNG TSENG ; Wu, Jo-Hsuan; PEI-JER CHEN ; JIA-HORNG KAO | Journal of clinical medicine | 0 | 0 | |
2017 | Src-homology protein tyrosine phosphatase-1 agonist, SC-43, reduces liver fibrosis | TUNG-HUNG SU ; Shiau C.-W; Jao P; Yang N.-J; Tai W.-T; CHUN-JEN LIU ; TAI-CHUNG TSENG ; HUNG-CHIH YANG ; CHEN-HUA LIU ; KAI-WEN HUANG ; Hu T.-C; Huang Y.-J; YAO-MING WU ; Chen L.-J; PEI-JER CHEN ; DING-SHINN CHEN ; Chen K.-F; JIA-HORNG KAO | Scientific Reports | 12 | 11 | |
2007 | Subgenotypes of hepatitis B virus genotype C do not correlate with disease progression of chronic hepatitis B in Taiwan | TAI-CHUNG TSENG ; CHUN-JEN LIU ; PEI-JER CHEN ; Lai M.-Y.; Lin C.-L.; JIA-HORNG KAO ; DING-SHINN CHEN | Liver International | 15 | 15 | |
2005 | Subgenotypes of hepatitis B virus genotype C in Taiwan [3] (multiple letters) | CHUN-JEN LIU ; JIA-HORNG KAO ; Chan H.L.-Y. | Journal of Infectious Diseases | 4 | 4 | |
2020 | Successful antiviral therapy reduces risk of schizophrenia among chronic hepatitis c patients: A nationwide real-world Taiwanese cohort (T-COACH) | Tsai P.-C.; Chen C.-Y.; Kuo H.-T.; Hung C.-H.; Tseng K.-C.; Lai H.-C.; Peng C.-Y.; Wang J.-H.; Chen J.-J.; Lee P.-L.; Chien R.-N.; Yang C.-C.; Lo G.-H.; JIA-HORNG KAO ; CHUN-JEN LIU ; CHEN-HUA LIU ; Yan S.-L.; Bair M.-J.; Lin C.-Y.; Su W.-W.; Chu C.-H.; Chen C.-J.; Tung S.-Y.; Tai C.-M.; Lin C.-W.; Lo C.-C.; Cheng P.-N.; Chiu Y.-C.; Wang C.-C.; Cheng J.-S.; Tsai W.-L.; Lin H.-C.; Huang Y.-H.; Yeh M.-L.; Huang C.-F.; Hsieh M.-H.; Huang J.-F.; Dai C.-Y.; Chung W.-L.; Ke C.-L.K.; Yu M.-L.; T-COACH Study Group | Open Forum Infectious Diseases | 3 | 3 | |
2005 | Successful treatment of acute hepatitis A-associated hemophagocytic syndrome by intravenous immunoglobulin | Tai C.-M.; CHUN-JEN LIU ; MING YAO | Journal of the Formosan Medical Association | 11 | 14 | |
2013 | Sustained hepatitis C virus clearance and increased hepatitis B surface antigen seroclearance in patients with dual chronic hepatitis C and B during posttreatment follow-up | Yu M.-L.; Lee C.-M; CHI-LING CHEN ; Chuang W.-L; Lu S.-N; CHEN-HUA LIU ; Wu S.-S; Liao L.-Y; Kuo H.-T; Chao Y.-C; Tung S.-Y; Yang S.-S; JIA-HORNG KAO ; Su W.-W; Lin C.-L; HUNG-CHIH YANG ; PEI-JER CHEN ; DING-SHINN CHEN ; CHUN-JEN LIU | Hepatology | 65 | 59 | |
2020 | Sustained virological response to hepatitis C therapy does not decrease the incidence of systemic lupus erythematosus or rheumatoid arthritis | Hsu W.-F.; Chen C.-Y.; Tseng K.-C.; Lai H.-C.; Kuo H.-T.; Hung C.-H.; Tung S.-Y.; Wang J.-H.; Chen J.-J.; Lee P.-L.; Chien R.-N.; Lin C.-Y.; Yang C.-C.; Lo G.-H.; Tai C.-M.; Lin C.-W.; JIA-HORNG KAO ; CHUN-JEN LIU ; CHEN-HUA LIU ; Yan S.-L.; Bair M.-J.; Su W.-W.; Chu C.-H.; Chen C.-J.; Lo C.-C.; Cheng P.-N.; Chiu Y.-C.; Wang C.-C.; Cheng J.-S.; Tsai W.-L.; Lin H.-C.; Huang Y.-H.; Tsai P.-C.; Huang J.-F.; Dai C.-Y.; Chuang W.-L.; Yu M.-L.; Peng C.-Y. | Scientific Reports | 4 | 4 | |